EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of mitophagy‐associated proteins profile as potential plasma biomarkers of idiopathic Parkinson's disease

Shuangjie Qian, Haijun He, Xi Xiong, Ruixue Ai, Wenwen Wang, Huimin Zhu, Qianqian Ye, Shuoting Zhou, Hilde Nilsen, Chenglong Xie

CNS Neuroscience & Therapeutics · 2024-04 · 30 (4)

DOI: 10.1111/cns.14532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 21.11.2023. Verfasst von Shuangjie Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Parkinson Disease, Biomarkers, Mitophagy, Protein Kinases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Projects of the National Science Foundation of China, Projects of the Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite extensive work to identify diagnostic plasma markers for Parkinson's disease (PD), there are still no accepted and validated surrogate biomarkers. Mitophagy‐associated proteins (MAPs), including PTEN‐induced putative kinase 1 (PINK1), Parkin, phosphoglycerate mutase 5 (PGAM5), BCL2 interacting protein 3 (BNIP3), and phosphorylated‐TBK1 (p‐TBK1), are, to our best knowledge, not well studied as a panel of biomarkers of neurodegeneration in PD.

Methods

The study population comprised 116 age‐matched controls (HC), 179 PD patients, alongside and 90 PD syndromes (PDs) divided between two cohorts: (i) the modeling cohort (cohort 1), including 150 PD, 97 HC, and 80 PDs; and (ii) the validated cohort (cohort 2), including 29 PD, 19 HC, and 10 PDs.

Results

MAPs are elevated in the plasma of PD patients. PINK1, Parkin, and PGAM5 displayed the top three measurable increase trends in amplitude compared to BNIP3 and p‐TBK1. Moreover, the area under the curve (AUC) values of PINK1, PGAM5, and Parkin were ranked the top three MAP candidates in diagnosis accuracy for PD from HC, but the MAPs make it hard to differentiate PD from PDs. In addition, there are higher plasma PINK1‐Parkin levels and prominent diagnostic accuracy in A‐synuclein (+) subjects than in A‐synuclein (−) subjects.

Conclusions

These results uncover that plasma MAPs (PINK1, Parkin, and PGAM5) may be potentially useful diagnostic biomarkers for PD diagnosis. Studies on larger cohorts would be required to test whether elevated plasma MAP levels are related to PD risk or prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseBiomarkersMitophagyProtein KinasesUbiquitin-Protein LigasesHumansMaleFemaleAgedMiddle AgedCohort StudiesMitochondrial ProteinsMembrane ProteinsProtein Serine-Threonine KinasesProto-Oncogene ProteinsPhosphoprotein PhosphatasesPTEN-Induced Putative Kinase

Stichwörter der Autor:innen

MAPsParkinson's diseasebiomarkersdiagnosismitophagy‐associated proteins

Substanzen

BiomarkersProtein KinasesUbiquitin-Protein LigasesMitochondrial ProteinsMembrane ProteinsProtein Serine-Threonine KinasesProto-Oncogene ProteinsPhosphoprotein PhosphatasesPTEN-Induced Putative Kinaseparkin protein

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.
  • The Center of Traditional Chinese Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  • Institute of Clinical Medicine, Department of Clinical Molecular Biology, University of Oslo, Oslo, Norway.
  • Unit of Precision Medicine, Akershus University Hospital, Nordbyhagen, Norway.

Förderung

  • Projects of the National Science Foundation of China
  • Projects of the Natural Science Foundation of Zhejiang Province

Zitieren

APA

Qian, S., He, H., Xiong, X., Ai, R., Wang, W., Zhu, H., Ye, Q., Zhou, S., Nilsen, H., & Xie, C. (2024). Identification of mitophagy‐associated proteins profile as potential plasma biomarkers of idiopathic Parkinson's disease. CNS Neuroscience & Therapeutics, 30(4). https://doi.org/10.1111/cns.14532

Vancouver

Qian S, He H, Xiong X, Ai R, Wang W, Zhu H, et al. Identification of mitophagy‐associated proteins profile as potential plasma biomarkers of idiopathic Parkinson's disease. CNS Neuroscience & Therapeutics. 2024;30(4). doi:10.1111/cns.14532

BibTeX
@article{Qian2024,
  author = {Qian, Shuangjie and He, Haijun and Xiong, Xi and Ai, Ruixue and Wang, Wenwen and Zhu, Huimin and Ye, Qianqian and Zhou, Shuoting and Nilsen, Hilde and Xie, Chenglong},
  title = {Identification of mitophagy‐associated proteins profile as potential plasma biomarkers of idiopathic Parkinson's disease},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  volume = {30},
  number = {4},
  doi = {10.1111/cns.14532}
}
Kostenlos starten →